Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/117877
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSun, E.W.en
dc.contributor.authorMartin, A.M.en
dc.contributor.authorYoung, R.L.en
dc.contributor.authorKeating, D.J.en
dc.date.issued2019en
dc.identifier.citationFrontiers in Endocrinology, 2019; 9(JAN):1-11en
dc.identifier.issn1664-2392en
dc.identifier.issn1664-2392en
dc.identifier.urihttp://hdl.handle.net/2440/117877-
dc.description.abstractEnteroendocrine cells lining the gut epithelium constitute the largest endocrine organ in the body and secrete over 20 different hormones in response to cues from ingested foods and changes in nutritional status. Not only do these hormones convey signals from the gut to the brain via the gut-brain axis, they also act directly on metabolically important peripheral targets in a highly concerted fashion to maintain energy balance and glucose homeostasis. Gut-derived hormones released during fasting tend to be orexigenic and have hyperglycaemic potential. Conversely, gut hormones secreted postprandially generally promote satiety and facilitate glucose clearance. Although some of the metabolic benefits conferred by bariatric surgeries have been ascribed to changes in the secretory profiles of various gut hormones, the therapeutic potential of the enteroendocrine system as a viable target against metabolic diseases remain largely underexploited, except for incretin-mimetics. This review provides a brief overview of the physiological importance and highlights the therapeutic potential of the following gut hormones: serotonin, glucose-dependent insulinotropic peptide, glucagon-like peptide 1, oxyntomodulin, peptide YY, insulin-like peptide 5, and ghrelin.en
dc.description.statementofresponsibilityEmily W.L. Sun, Alyce M. Martin, Richard L. Young and Damien J. Keatingen
dc.language.isoenen
dc.publisherFrontiers Mediaen
dc.rights© 2019 Sun, Martin, Young and Keating. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these termsen
dc.subjectGLP-1; PYY; serotonin; GIP-glucose-dependent insulinotropic peptide; oxyntomodulin; ghrelin; enteroendocine cells; insulin-like peptide 5 (INSL5)en
dc.titleThe regulation of peripheral metabolism by gut-derived hormonesen
dc.typeJournal articleen
dc.identifier.rmid0030106774en
dc.identifier.doi10.3389/fendo.2018.00754en
dc.identifier.pubid455197-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS14en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidYoung, R.L. [0000-0001-5116-4951]en
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_117877.pdfPublished version986.42 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.